Crossmark

Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria

Published Online: 2020-09-12

Published Print: 2020-12

Authors

Seelbinder, Bastian

Chen, Jiarui

Brunke, Sascha

Vazquez-Uribe, Ruben

Santhaman, Rakesh

Meyer, Anne-Christin

de Oliveira Lino, Felipe Senne

Chan, Ka-Fai

Loos, Daniel

Imamovic, Lejla

Tsang, Chi-Ching

Lam, Rex Pui-kin

Sridhar, Siddharth

Kang, Kang

Hube, Bernhard

Woo, Patrick Chiu-yat

Sommer, Morten Otto Alexander

Panagiotou, Gianni https://orcid.org/0000-0001-9393-124X
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (CRC/Transregio 124)

Novo Nordisk Fonden (NNF10CC1016517, NNF17CO0028232)

Lundbeckfonden (R140-2013-13496)
License Information

Text and Data Mining valid from 2020-09-12

Version of Record valid from 2020-09-12
More Information

Article History

Received: 15 May 2020

Accepted: 24 July 2020

First Online: 12 September 2020

Ethics approval and consent to participate

: The Danish study was approved by the local ethics committee in Region Zealand, Denmark (SJ-383). The Hong Kong study was approved by the Institutional Review Board of The University of Hong Kong/Hospital Authority Hong Kong West Cluster (UW 17-042).

: Not applicable.

: The authors declare that they have not competing interests.

Document is current